» Articles » PMID: 30802343

CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines

Overview
Journal Biotechnol J
Specialty Biotechnology
Date 2019 Feb 26
PMID 30802343
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are noncoding RNAs that serve as versatile molecular engineering tools to improve production cells by overexpression or knockdown of miRNAs showing beneficial or adverse effects on cell-culture performance. The genomic knockout (KO) of noncoding RNAs in Chinese hamster ovary (CHO) production cells has not been reported. However, given the significant number of miRNAs showing negative effects on CHO-bioprocess performance and the development of clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR/Cas9), genome editing tools facilitate precise optimization of CHO cells via modulation of noncoding RNAs. In a previous high-content miRNA screen, miR-744 was identified as a potential target associated with reduced productivity. Hence, the genomic miR-744 precursor sequence is deleted by two single guide RNA (sgRNA)-Cas9-mediated DNA double-strand breaks (DSB) flanking the miR-744 locus. After fluorescence-activated cell sorting (FACS), clonal miR-744 KO cell lines are recovered and three of them are confirmed as miR-744 KOs. Impacts of CRISPR/Cas9 editing are characterized at the genetic, transcript, and phenotypic levels. During batch cultivation, antibody titers of miR-744 KOs are significantly increased to 190-311 mg L compared to a nontargeting (NT) sgRNA transfected clonal control with 156 mg L , pointing towards the potential of miRNA KO for cell line engineering.

Citing Articles

CRISPR Deletion of miR-27 Impacts Recombinant Protein Production in CHO Cells.

Kellner K, Lao N, Barron N Methods Mol Biol. 2024; 2810:285-300.

PMID: 38926286 DOI: 10.1007/978-1-0716-3878-1_18.


Therapeutic proteins: developments, progress, challenges, and future perspectives.

Kumar V, Barwal A, Sharma N, Mir D, Kumar P, Kumar V 3 Biotech. 2024; 14(4):112.

PMID: 38510462 PMC: 10948735. DOI: 10.1007/s13205-024-03958-z.


Enhancing protein production and growth in chinese hamster ovary cells through miR-107 overexpression.

Jari M, Abdoli S, Bazi Z, Tash Shamsabadi F, Roshanmehr F, Shahbazi M AMB Express. 2024; 14(1):16.

PMID: 38302631 PMC: 10834913. DOI: 10.1186/s13568-024-01670-y.


CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering.

Glinsek K, Bozovicar K, Bratkovic T Int J Mol Sci. 2023; 24(9).

PMID: 37175850 PMC: 10179654. DOI: 10.3390/ijms24098144.


Overexpression of miR-32 in Chinese hamster ovary cells increases production of Fc-fusion protein.

Bazaz M, Adeli A, Azizi M, Karimipoor M, Mahboudi F, Davoudi N AMB Express. 2023; 13(1):45.

PMID: 37160545 PMC: 10170017. DOI: 10.1186/s13568-023-01540-z.